PROMOGRAN PRISMA® matrix is a freeze-dried composite of collagen, oxidised regenerated cellulose (ORC) and silver
- Made from a matrix of 55% collagen, 44% ORC and 1% ORC/Silver
PROMOGRAN PRISMA® matrix is designed to ‘kick start’ the healing process while providing protection from infection.1-2
In the presence of exudate PROMOGRAN PRISMA® matrix transforms into a soft and conformable, biodegradable gel; this allows contact with all areas of the wound.
With PROMOGRAN PRISMA® Stalled wounds close:
- Cost Effectively3,6
- While providing protection from infection7-8
Click this link to view PROMOGRAN PRISMA® product codes
- Early adoption of Collagen/ORC therapies improves venous leg ulcers and diabetic foot ulcers
- EPA modulating therapies: the ability of collagen/ORC to reduce EPA and facilitate healing
The product information on this page is not intended to be used by health care professinoals or users in the United States and may not comply with the regulatory standards of the United States – please click the link above for product information in respect of products used in the United States
© Systagenix Wound Management 2011. Brands marked with ® or ™ are trademarks of Systagenix. All other products referenced herein are acknowledged to be trademarks of their respective owners.rs.
PROMOGRAN PRISMA® References
1. Cullen B et al. ORC/Collagen Matrix Containing Silver Controls Bacterial Bioburden while Retaining Dermal Cell viability. Poster presented at EWMA Prague, May 2006
2. Gregory S et al. The Ability of ORC/Collagen containing silver to reduce Bioburden and retain dermail Cell Viability. Johnson & Johnson Wound Management, Gargrave, UK. Poster presented at ETRS Stuttgart, September 2005
5. Veves A et al. A randomized , controlled trial of PROMOGRAN® (a collagen/oxidised regenerated cellulose dressing) vs standard treatments in the management of diabetic foot ulcers. Arch Surg 2002;137:822-827
6. Cullen, B., Domnelly, T., Rennison, T. Can excessive levels of silver be detrimental to healing? SAWC, San Diego, 2008
7. Gregory S et al. The Ability of ORC/Collagen containing silver to reduce Bioburden and retain dermail Cell Viability. Johnson & Johnson Wound Management, Gargrave, UK. Poster presented at ETRS Stuttgart, September 2005
8. Cullen, B., Nisbet, L., Gibson, M., Lanzara, S., Zamboni, P. A clinical study examining the effect of ORC/Collagen/Silver-ORC on healing and wound biochemistry. SAWC, Dallas, 2009
11. (relates to graph) Cullen, B., Kemp, L., Essler, L. Rebalancing wound biochemistry improves healing: a clinical study examining effect of PROMOGRAN. Wound Repair Regen. 2004 12(2) A4.